Peer Review History
| Original SubmissionDecember 9, 2019 |
|---|
|
PONE-D-19-34050 Cataract Surgery Visual Outcomes and Associated Risk Factors in Liberia PLOS ONE Dear Professor Khanna, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The comments are attached. We would appreciate receiving your revised manuscript by Apr 17 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Fakir M Amirul Islam, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following financial disclosure: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." a) Please provide an amended Funding Statement that declares *all* the funding or sources of support received during this specific study (whether external or internal to your organization) as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. b) Please state what role the funders took in the study. If any authors received a salary from any of your funders, please state which authors and which funder. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study presents the cataract surgery outcomes of the Liberia Eye Health Initiative by the LVPEI and highlights risk factors for poor outcome. The study is simple and the results clearly presented, but some grammar editing and proofreading is required to facilitate readability. Recalculation of some figures in the tables would also be helpful. I have included some suggestions below. Line 28: ‘Since July 2017, LV’ Putting this at end of sentence would improve flow Line 44: recommendation, not ‘recommended’ Line 51: of, not ‘for’ Line 54: from blindness of which 50% is due to cataract. Add comma after blindness Line 54-56: In terms of human resources, there is only one ophthalmologist for one million population on an average in the sub-Saharan region. Rephrase: In terms of human resources, the sub-Saharan region has on average only one ophthalmologist per one million population. Line 56: This holds true even for Liberia [4] Add full stop at end of sentence Line 63-65 : The L V Prasad Eye Institute’s (LVPEI) pyramidal model of eye care delivery has a Centre of Excellence (CoE) at the top catering to a population of 50 million population with Tertiary Centres (TC) at the next level, each for 5 million population.[10] add commas after 'top' and '50 million' to improve clarity Line 80: The Liberia Eye Centre (LEC) 80 was formally inaugurated on 24 July 2017 in Monrovia, to provide comprehensive eye care 81 for people of Liberia. Delete comma Line 81-82 Since 2018, LVPEI also started the ophthalmology residency training program in Liberia. Suggest delete this line: irrelevant and disrupts the flow (unless this study involves this program?) Line 82-84 The purpose of this study is to evaluate outcomes of cataract surgery performed, at the LEC as well as associated risk factors for poor outcomes. Delete comma Line 132: While 562 (98.1%) eyes underwent PCIOL, 11 (1.9 %) eyes were either left aphakic or had an ACIOL. Rephrase; try not to start sentence with 'while' Line 133-136: Major intraoperative complications such as posterior capsular rest and zonular dehiscence were noted in 3.3% eyes. Other complications (0.9%) such as Descemet’s membrane detachment (1eye), iridodialysis (2 eyes) and would leak (2 eyes) were also noted. -33% 'of' eyes - Note spacing between ‘1’ and ‘eye’ - Generally, when quoting figures below ten, they should be spelt in full (eg. one eye) Line 138-139: Table 2 shows the preoperative and post-operative (uncorrected and best corrected) visual acuity first day; 1 to 3 weeks and 4-11 weeks follow up. …visual acuity ‘on the’ first day Line 162: Those with poor outcomes were older (p=0.04); had higher intraoperative complications (p<0.001) as well as associated ocular comorbidity (<0.001); and had no IOL and AC IOL (p=0.001). It would be clearer to say ‘and had either an ACIOL or were left aphakic’ Line 183: We reported here the outcomes of cataract surgeries performed by in a new facility 184 built in Liberia. Replace with 'present' Line 185: ‘We started this new facility in July 2017, and installed the Electronic Medical Records (EMR) system to collect and store patient data on a daily basis. This is a good source for monitoring the outcomes of cataract surgery.’ Comment: This part is not relevant in discussion. Please delete. Any discussion of methods eg EMR should be in Methods. Line 189: The only report from Liberia by Frucht-Pery and Feldman, on cataract surgical outcomes in 190 patients with leprosy, showed that a visual acuity of 20/200 or better was achieved in 65% of 191 patients. Add comma after Liberia Line 191: However, this study published more than 25 years ago, included only 43 eyes and 192 the surgical technique used was intracapsular or extracapsular cataract extraction. -grammar: ‘…this study, which was published ...’ Line 198-202: There are very few reports on outcomes of cataract surgery from Africa, and outcomes reported by these are not encouraging, except a few centres. One of the reasons for this was the availability of well-trained surgeons performing high volume work in these centres. However, outcomes were better than many other studies from Africa, including PRECOG study. This could be due to availability 203 of well-trained surgeons, accurate biometry in all cases, availability of equipment and consumables, and well trained staff. Please rephrase for clarity and readability. For example, by 'one of the reasons for this', it is unclear if you mean the reason for the poor outcome or the exceptions. and when you say' outcomes were better than many other studies', to which outcomes do you refer? Line 208: The outcomes were also similar to the recommended rates of WHO for BCVA (BCVA of 90% having 6/18 or better), but were less than what is recommended for UCVA. Rephrase sentence… Line 212: This implies better quality of life for those blind or SVI before cataract surgery. Use either 'severely visually impaired' or 'with SVI' Line 224: Unlike other studies, we did not find age or presence of a complication as a risk factor for poor outcomes Replace ‘as’ with ‘to be’ Line 226: No devastating complications like expulsive choroidal haemorrhage or endophthalmitis were report, though the number of surgeries was less. Reported, not ‘report’ Line 236: Patients with ocular comorbidities, can then be counselled with a clear explanation on the outcomes of surgery. Delete comma Line 239: However, when we compared those available and those lost to follow up, we found that they differed in terms of age group, operating surgeon, and presence of ocular comorbidity. Suggest rephrase… there was a statistically significant difference between the two groups only in terms of age group, operating surgeon, and presence of ocular comorbidity. Line 241: Those available for follow up had higher prevalence of ocular comorbidity. ‘had a higher’ Line 242: PRECOG study also showed good correlation between early outcome (3 or fewer days) and 40 days or more post operatively. Delete ‘also’ (you have it in the next sentence too) Line 245: Hence, the results obtained from those available for follow up can underestimate the good outcomes. ‘may’, instead of ‘can’ Conclusion: Rephrase to link the thoughts/clarify your recommendations. Eg. you might suggest, after your sentence re well trained staff, that the planned residency program is a move in such a direction. Whether regular monitoring would improve the catarat outcomes in patients with ocular comorbidities is doubtful- in this case, screening and prevention (where possible) of primary disease may be more relevant. Tables: Table 1: Please check formatting of table. ? no line between ‘HIV seropositive’ and ‘none’...? Table 3: Since you are comparing between those whose follow up was available vs not, the percentages should be by column (eg gender: Female 222/285 = 77.9%). Likewise for table 4 (good vs poor outcome) Reviewer #2: While commending the efforts of the authors , i will wish to state that this manuscript has significant flaws. First is the title. A change ought to be considered to reflect the fact that the "risk factor" considered was for poor outcome. The title as it is "Cataract Surgery Visual Outcomes and Associated Risk Factors in Liberia" does not reflect this point. The authors only considered visual acuity using distant snellen acuity and there was no information on near vision. It would have been of benefit to give an idea of the post operative refractive outcome ie myopia, hyperopia or astigmatism within a specified range of diopters. A significant concern is a lack of description of the process. There is need to inform the readers of what process the patient has to go through. A step wise description of the process from the point of patient contact and diagnosis, through the preoperative workup and surgical technique should be included in the manuscript. What was the basis for selection to perform MSICs or Phacoemulsification? No information on biometry was given ie was biometry done and at what point? There is no information on if there was a patient counseling, and by whom. Was there a patient participation in decision to surgery? Patient consent was not mentioned, let alone discussed. Can an explanation for the high number of failure to attend 4 to11 week follow up clinic visit be given. There are other significant points requiring attention in the attached manuscript. This has been included as comments in the manuscript. Click on the comments icon at each point to view the question. Reviewer #3: Why were most patients operated using MSICS and not phacoemulsification? Only a total of 86.8% received intracameral antibiotics, what informed this decision and did this information affect any of the measured outcomes? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Evelyn Tai Reviewer #2: Yes: OGUGUA, N. OKONKWO Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Factors associated with Visual Outcomes after Cataract Surgery: A cross-sectional or retrospective study in Liberia PONE-D-19-34050R1 Dear Professor Khanna, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Fakir M Amirul Islam, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Authors, Congratulations on your work. It is accepted. However, I would suggest to fix the formatting issues before it publishes. I have not liked the formatting of the Tables which do not look fantastic. For example, Table 1: Number of Patients (percentage). If it gives 38 (6.6%) and so on. Does it not using the percentage twice? Either it should be removed from the title line or from the numbers. Removing from the numbers (inside of the tables) is preferred because it will give extra space to accommodate not for Table 1 but for other tables. Table 2 is taking two rows due to keeping the percentage. It could be looked better. Still OK Table 3: There is no title in the first two columns (characteristics and labels of characteristics). These two columns could be presented in one column bringing the labels of characteristics under the characteristics. This would give ample space to fit everything in Tables 3 & 4. I WOULD NOT KEEP THIS SILLY MISTAKES AND FORMATTING ISSUES LEFT FOR THE REVIEWERS/EDITOR. P values are mainly with two decimal places but one is with one decimal place. Sometimes, there are spaces between parenthesis and words and sometimes not. Should be very consistent throughout. There are some footnotes in Table 3. However, the symbol choice seems random. *, plus sign (+), cross sign...........comes before these. These are formatting issue which is just a matter of last-minute work to fix after a long time work. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-34050R1 Factors associated with Visual Outcomes after Cataract Surgery: A cross-sectional or retrospective study in Liberia Dear Dr. Khanna: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr Fakir M Amirul Islam Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .